HCPCS code J0175 — Inj, donanemab-azbt, 2 mg. Status: Active. Effective Jul 2, 2024. Source: CMS HCPCS Level II.

J0175

Active

Inj, donanemab-azbt, 2 mg

Injection, donanemab-azbt, 2 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 2, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0765

MUE — Medically Unlikely Edits

Maximum units of J0175 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 700
Outpatient Hospital 700
Practitioner Services 700

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00002-9401-01 Kisunla

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q3
    Inj, donanemab-azbt, 2 mg